821 related articles for article (PubMed ID: 15196634)
21. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Bozdag S; Dillen K; Vandervoort J; Ludwig A
J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
[TBL] [Abstract][Full Text] [Related]
22. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
23. The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye.
Raut SL; Kirthivasan B; Bommana MM; Squillante E; Sadoqi M
Nanotechnology; 2010 Oct; 21(39):395102. PubMed ID: 20820096
[TBL] [Abstract][Full Text] [Related]
24. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
[TBL] [Abstract][Full Text] [Related]
26. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
Song X; Zhao Y; Wu W; Bi Y; Cai Z; Chen Q; Li Y; Hou S
Int J Pharm; 2008 Feb; 350(1-2):320-9. PubMed ID: 17913411
[TBL] [Abstract][Full Text] [Related]
27. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
28. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles.
Shi K; Cui F; Yamamoto H; Kawashima Y
Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901
[TBL] [Abstract][Full Text] [Related]
29. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid.
Ma Y; Sadoqi M; Shao J
Int J Pharm; 2012 Oct; 436(1-2):25-31. PubMed ID: 22692077
[TBL] [Abstract][Full Text] [Related]
31. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
32. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
33. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
Kang BK; Chon SK; Kim SH; Jeong SY; Kim MS; Cho SH; Lee HB; Khang G
Int J Pharm; 2004 Nov; 286(1-2):147-56. PubMed ID: 15501011
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
35. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.
Ozturk K; Caban S; Kozlu S; Kadayifci E; Yerlikaya F; Capan Y
Pharmazie; 2010 Sep; 65(9):665-9. PubMed ID: 21038843
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yin Y; Chen D; Qiao M; Lu Z; Hu H
J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
[TBL] [Abstract][Full Text] [Related]
38. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
39. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
40. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Yin J; Noda Y; Yotsuyanagi T
Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
